Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
51.5 EUR | 0.00% |
|
+7.74% | -16.94% |
Feb. 26 | Jefferies Adjusts GMO Payment’s Price Target to 11,000 Yen From 13,350 Yen, Keeps at Buy | MT |
2023 | Enpay Inc. announced that it has received ¥850 million in funding from a group of investors | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 66% by 2026.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 41.37 and 33.25 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.94% | 4.3B | - | ||
+13.30% | 88.06B | B | ||
-2.69% | 62.51B | B | ||
-14.96% | 40.65B | C- | ||
-4.29% | 19.01B | C+ | ||
-24.34% | 11.06B | A- | ||
-14.99% | 9.74B | C | ||
-19.28% | 8.25B | B+ | ||
-8.75% | 7.44B | C+ | ||
+0.61% | 4.68B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3769 Stock
- 3RH Stock
- Ratings GMO Payment Gateway, Inc.